跳至主要内容
临床试验/NCT05374980
NCT05374980已完成不适用

The Effects of Fermented Milk Product With Probiotic on Helicobacter Pylori Infection, Gut Microbiome and Metabolism.

Taichung Veterans General Hospital2 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
2
主要终点
Change of gut Microbiome

研究概览

简要总结

Helicobacter pylori is a common pathogen causing upper gastrointestinal diseases including gastric ulcer and gastric cancer. Recent epidemiological findings have also shown that it is also related to colon cancer, metabolic syndrome, gut dysbiosis, glycemic control and insulin resistance.

The aim of this study is to investigate whether the gut microbiota and insulin resistance of patients with H. pylori infection are abnormal. In addition, whether drinking fermented milk product with probiotic reduces Helicobacter pylori, improves gut microbiota, and increases butyrate-producing bacteria and insulin resistance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 20 to 70 years old with positive Helicobacter pylori gastric C13 urea breath test (ΔUBT>10%).
  • Negative gastric Helicobacter (ΔUBT<2%) matching age, gender, and body mass index.

排除标准

  • Unhealthy habits or poor health status, including habitual smoking, alcoholism, polypharmacy or drug abuses.
  • Patients with acute diseases, such as respiratory tract infection, acute gastroenteritis.
  • In the past three months, those who have had dyspepsia but have not undergone gastroscopy, or have a history of active gastrointestinal ulcers and gastrointestinal bleeding.
  • Those who have had gastrointestinal cancer or have undergone gastrointestinal surgery.
  • Those who are unwilling to delay receiving Anti-H. pylori therapy.
  • Newly diagnosed cancer (except basal cell carcinoma) or cancer treatment in the past 5 years.
  • People who have had cardiovascular disease, respiratory disease, autoimmune disease, mental disease or other chronic diseases that are not well controlled, such as myocardial infarction or stroke, chronic obstructive pulmonary disease, inflammatory bowel disease, Schizophrenia.
  • Diabetes and those who are or need to take drugs.
  • Those who have used the following drugs in the past month: antibiotics, NSAIDs, obesity drugs, steroid therapy, proton pump inhibitors, bismuth agents.
  • In the past month, regularly consume the following foods (at least 2 times a week): probiotics, prebiotics, or any foods containing probiotics, dairy products (yogurt, cheese), Chinese medicine, kimchi, miso, honey, cranberry, spicy food.
  • Fecal occult blood positive, unexplained iron-deficiency anemia, weight increase or decrease by more than 5% within six months.
  • Abnormal liver function index (AST, ALT or ALP greater than 2 times the upper limit of normal), abnormal renal function index (eGFR less than 45 ml/min).
  • Pregnant or breast-feeding women.

结局指标

主要结局

Change of gut Microbiome

时间窗: Baseline to day 28 and day 56

uses high-throughput sequencing to sequence the 16S rRNA

次要结局

  • Change of C13 urea breath test(Baseline to day 28 and day 56)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Han-Chung, Lien

Principle Investigator of Gastrointestinal Motility Lab

Taichung Veterans General Hospital

研究点 (2)

Loading locations...

相似试验